1. Altered interleukin-2 secretion in patients with primary fibromyalgia syndrome
- Author
-
Nitza Lahat, David Rimon, Amalia Kinarty, and Nader Hader
- Subjects
Antigens, Differentiation, T-Lymphocyte ,CD4-Positive T-Lymphocytes ,Interleukin 2 ,medicine.medical_specialty ,Fibromyalgia ,CD8 Antigens ,medicine.medical_treatment ,Immunology ,chemistry.chemical_element ,Calcium ,Lymphocyte Activation ,Lymphocyte Depletion ,Rheumatology ,Internal medicine ,Concanavalin A ,medicine ,Humans ,Immunology and Allergy ,Pharmacology (medical) ,Secretion ,Calcimycin ,biology ,business.industry ,T lymphocyte ,medicine.disease ,Endocrinology ,Cytokine ,chemistry ,CD4 Antigens ,biology.protein ,Interleukin-2 ,Tetradecanoylphorbol Acetate ,business ,CD8 ,T-Lymphocytes, Cytotoxic ,medicine.drug - Abstract
Interleukin-2 (IL-2) production was studied in T lymphocytes and isolated CD4+ T lymphocytes from 12 patients with primary fibromyalgia syndrome and 10 healthy volunteers. The dose and time kinetics of IL-2 production by concanavalin A-stimulated T cells and CD4+ T cells of fibromyalgia patients differed from findings in controls by 1) a need for a higher concentration of mitogen in order to achieve optimal IL-2 secretion, and 2) a delay in the peak time of optimal IL-2 secretion. Unlike normal IL-2 secretion, which was higher after removal of CD8+ T cells, the pattern and degree of IL-2 secretion by cells from fibromyalgia patients were not changed following removal of CD8+ T cells. Addition of calcium ionophore in assays using suboptimal concanavalin A concentrations did not correct the reduction in IL-2 secretion by fibromyalgia patient T cells, but addition of phorbol myristate acetate induced normal secretion of IL-2. These findings suggest that there is a defect in the IL-2 pathway, which is related to protein kinase C activation and does not involve impairment of Ca2+ elevation, in patients with fibromyalgia.
- Published
- 1991